Approval · Notice of Compliance 33152 · 2024
QULIPTA: Notice of Compliance 33152
Issued May 2, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33152
- Date
- May 2, 2024
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Indication, Dosage and Administration section, and safety updates to the Product Monograph (PM).
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| QULIPTA | Not yet assigned | — |